Kotak Healthcare Fund-Direct Plan-Growth vs HDFC Pharma and Healthcare Fund Direct Plan IDCW Reinvestment
NAV, returns and costs — not a recommendation.
 Kotak Healthcare Fund-Direct Plan-Growth |  HDFC Pharma and Healthcare Fund Direct Plan IDCW Reinvestment | |
|---|---|---|
| NAV | ₹17.394 | ₹22.3 |
| NAV date | 2026-08-19 | 2026-08-18 |
| 1 year | +23.83% | +25.46% |
| 3 year (p.a.) | +22.86% | +32.38% |
| 5 year (p.a.) | +22.86% | +32.38% |
| Expense ratio | 0.87% | 0.92% |
| Fund size | ₹560.17 Cr | ₹2362.44 Cr |
| Risk | — | — |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.